Advancing drug discovery through enhanced free energy calculations

R Abel, L Wang, ED Harder, BJ Berne… - Accounts of chemical …, 2017 - ACS Publications
Conspectus A principal goal of drug discovery project is to design molecules that can tightly
and selectively bind to the target protein receptor. Accurate prediction of protein–ligand …

A critical review of validation, blind testing, and real-world use of alchemical protein-ligand binding free energy calculations

R Abel, L Wang, DL Mobley… - Current topics in …, 2017 - ingentaconnect.com
Protein-ligand binding is among the most fundamental phenomena underlying all molecular
biology, and a greater ability to more accurately and robustly predict the binding free energy …

Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2

H Schönherr, P Ayaz, AM Taylor… - Proceedings of the …, 2024 - National Acad Sciences
Fibroblast growth factor receptor (FGFR) kinase inhibitors have been shown to be effective
in the treatment of intrahepatic cholangiocarcinoma and other advanced solid tumors …

Large-scale assessment of binding free energy calculations in active drug discovery projects

CEM Schindler, H Baumann, A Blum… - Journal of Chemical …, 2020 - ACS Publications
Accurate ranking of compounds with regards to their binding affinity to a protein using
computational methods is of great interest to pharmaceutical research. Physics-based free …

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies

A Mahmoud, A Mostafa, AA Al-Karmalawy, A Zidan… - Heliyon, 2021 - cell.com
Drug repurposing is an important approach to the assignment of already approved drugs for
new indications. This technique bypasses some steps in the traditional drug approval …

Structural basis of AZD9291 selectivity for EGFR T790M

XE Yan, P Ayaz, SJ Zhu, P Zhao, L Liang… - Journal of medicinal …, 2020 - ACS Publications
AZD9291 (Osimertinib) is highly effective in treating EGFR-mutated non-small-cell lung
cancers (NSCLCs) with T790M-mediated drug resistance. Despite the remarkable success …

Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerization

C Agnew, P Ayaz, R Kashima, HS Loving… - Nature …, 2021 - nature.com
Upon ligand binding, bone morphogenetic protein (BMP) receptors form active tetrameric
complexes, comprised of two type I and two type II receptors, which then transmit signals to …

[HTML][HTML] An In-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor

NH Aljarba, MS Hasnain, MM Bin-Meferij… - Journal of King Saud …, 2022 - Elsevier
The deadliest recent pandemic outbreak of COVID-19 disease has severely damaged the
socio-economic health of the people globally. Due to unavailability of any effective vaccine …

Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers

MR Campbell, A Ruiz-Saenz, E Peterson, C Agnew… - Cell reports, 2022 - cell.com
Effective inactivation of the HER2-HER3 tumor driver has remained elusive because of the
challenging attributes of the pseudokinase HER3. We report a structure-function study of …

[HTML][HTML] Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors

MS Aleissa, ALZ Mohammed, MS Hasnain… - Journal of King Saud …, 2022 - Elsevier
Abstract Coronavirus (covid-19) infection is considered to be deadliest ever pandemic
experienced by the human being. It has very badly affected the socio-economic health of …